UNIVERSAL SCIENTIFIC INDUSTRIAL (SHANGHAI) CO., LTD. Financials Universal Scientific Industrial (Shanghai) Co., Ltd.
Equities
601231
CNE100001BZ8
Electronic Equipment & Parts
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.72 CNY | +3.01% |
|
+11.18% | -2.58% |
| Apr. 25 | USI's Q1 Profit Rises 21%, Operating Income Jumps 4% | MT |
| Apr. 24 | Universal Scientific Industrial Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 41,592 | 42,473 | 35,305 | 35,351 | 33,029 | 32,187 | - | - |
| Enterprise Value (EV) 1 | 37,389 | 40,462 | 36,688 | 35,964 | 29,800 | 29,394 | 26,719 | 27,139 |
| P/E ratio | 33.2 x | 24.2 x | 19.3 x | 12 x | 17.4 x | 14.4 x | 10 x | 9.58 x |
| Yield | 0.91% | 2.59% | 1.62% | 2.65% | 1.79% | 2.09% | 2.9% | 3.25% |
| Capitalization / Revenue | 1.12 x | 0.89 x | 0.64 x | 0.52 x | 0.54 x | 0.48 x | 0.44 x | 0.4 x |
| EV / Revenue | 1 x | 0.85 x | 0.66 x | 0.52 x | 0.49 x | 0.44 x | 0.37 x | 0.34 x |
| EV / EBITDA | 19.5 x | 15.9 x | 11.9 x | 8.17 x | 9.13 x | 7.89 x | 6.19 x | 5.58 x |
| EV / FCF | 21.2 x | 101 x | -14 x | 19.2 x | 5.61 x | 21 x | 10.2 x | - |
| FCF Yield | 4.72% | 0.99% | -7.13% | 5.2% | 17.8% | 4.75% | 9.76% | - |
| Price to Book | 4.07 x | 3.48 x | 2.71 x | 2.33 x | 1.96 x | 1.75 x | 1.51 x | 1.4 x |
| Nbr of stocks (in thousands) | 2,162,886 | 2,196,145 | 2,198,310 | 2,178,104 | 2,185,902 | 2,186,604 | - | - |
| Reference price 2 | 19.23 | 19.34 | 16.06 | 16.23 | 15.11 | 14.72 | 14.72 | 14.72 |
| Announcement Date | 2/6/20 | 2/4/21 | 2/9/22 | 2/7/23 | 2/1/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 37,204 | 47,696 | 55,300 | 68,516 | 60,792 | 66,575 | 72,491 | 80,170 |
| EBITDA 1 | 1,921 | 2,543 | 3,073 | 4,400 | 3,263 | 3,728 | 4,320 | 4,868 |
| EBIT 1 | 1,422 | 1,962 | 2,132 | 3,461 | 2,178 | 2,472 | 3,374 | 3,712 |
| Operating Margin | 3.82% | 4.11% | 3.86% | 5.05% | 3.58% | 3.71% | 4.65% | 4.63% |
| Earnings before Tax (EBT) 1 | 1,433 | 1,974 | 2,139 | 3,477 | 2,190 | 2,506 | 3,740 | 3,826 |
| Net income 1 | 1,262 | 1,739 | 1,858 | 3,060 | 1,948 | 2,225 | 3,247 | 3,397 |
| Net margin | 3.39% | 3.65% | 3.36% | 4.47% | 3.2% | 3.34% | 4.48% | 4.24% |
| EPS 2 | 0.5800 | 0.8000 | 0.8300 | 1.350 | 0.8700 | 1.019 | 1.468 | 1.537 |
| Free Cash Flow 1 | 1,766 | 399.3 | -2,617 | 1,870 | 5,313 | 1,397 | 2,608 | - |
| FCF margin | 4.75% | 0.84% | -4.73% | 2.73% | 8.74% | 2.1% | 3.6% | - |
| FCF Conversion (EBITDA) | 91.97% | 15.7% | - | 42.5% | 162.83% | 37.48% | 60.38% | - |
| FCF Conversion (Net income) | 139.96% | 22.96% | - | 61.11% | 272.74% | 62.77% | 80.32% | - |
| Dividend per Share 2 | 0.1750 | 0.5000 | 0.2600 | 0.4300 | 0.2700 | 0.3072 | 0.4272 | 0.4779 |
| Announcement Date | 2/6/20 | 2/4/21 | 2/9/22 | 2/7/23 | 2/1/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 22,600 | 17,017 | 30,679 | 18,782 | 33,026 | 13,954 | 14,987 | 28,941 | 20,590 | 18,986 | 39,576 | 12,998 | - | 16,191 | 17,735 | 33,926 | 13,492 | 13,623 | 17,993 | 19,152 | 14,153 | 16,276 |
| EBITDA 1 | - | - | - | 985.6 | - | 719.3 | 858.2 | - | 1,412 | - | - | - | - | - | - | - | - | 685.3 | 1,006 | 1,029 | 898 | 1,024 |
| EBIT 1 | 979.4 | 564.1 | 1,398 | 861.2 | 1,509 | 499.6 | 720.1 | - | 1,244 | 996.8 | 2,241 | 302.4 | - | 678.6 | 645 | 1,324 | 383.4 | 397.6 | 718.1 | 741.3 | 580.6 | 706.5 |
| Operating Margin | 4.33% | 3.32% | 4.56% | 4.59% | 4.57% | 3.58% | 4.81% | - | 6.04% | 5.25% | 5.66% | 2.33% | - | 4.19% | 3.64% | 3.9% | 2.84% | 2.92% | 3.99% | 3.87% | 4.1% | 4.34% |
| Earnings before Tax (EBT) 1 | 985.8 | 568.9 | 1,405 | 858.8 | 1,504 | 500.8 | 722 | - | 1,260 | 994.8 | 2,254 | 305.7 | - | 679.7 | 647.3 | 1,327 | 389.7 | 405.1 | 739.8 | 780.7 | 615.3 | 746.5 |
| Net income 1 | 872.6 | 505.6 | 1,234 | 735.2 | 1,307 | 438.9 | 645.7 | - | 1,086 | 888.9 | 1,975 | 277.5 | - | 625.3 | 555.3 | 1,181 | 334.7 | 350 | 667 | 703.7 | 543.8 | 664.2 |
| Net margin | 3.86% | 2.97% | 4.02% | 3.91% | 3.96% | 3.15% | 4.31% | - | 5.28% | 4.68% | 4.99% | 2.13% | - | 3.86% | 3.13% | 3.48% | 2.48% | 2.57% | 3.71% | 3.67% | 3.84% | 4.08% |
| EPS 2 | 0.4000 | 0.2300 | 0.5700 | 0.3200 | 0.5800 | 0.2000 | 0.2800 | - | 0.4800 | 0.3900 | 0.8700 | 0.1300 | 0.2200 | 0.2800 | 0.2400 | 0.5200 | 0.1500 | 0.1584 | 0.3018 | 0.3184 | 0.2460 | 0.3006 |
| Dividend per Share 2 | - | - | - | 0.2600 | - | - | - | - | - | 0.4300 | - | - | - | - | - | - | - | - | - | 0.2843 | - | - |
| Announcement Date | 2/6/20 | 7/30/20 | 2/4/21 | 2/9/22 | 2/9/22 | 4/27/22 | 7/27/22 | 7/27/22 | 10/26/22 | 2/7/23 | 2/7/23 | 4/25/23 | 8/28/23 | 10/25/23 | 2/1/24 | 2/1/24 | 4/24/24 | - | - | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 1,384 | 614 | - | - | - | - |
| Net Cash position 1 | 4,203 | 2,011 | - | - | 3,229 | 2,793 | 5,468 | 5,048 |
| Leverage (Debt/EBITDA) | - | - | 0.4502 x | 0.1395 x | - | - | - | - |
| Free Cash Flow 1 | 1,766 | 399 | -2,617 | 1,870 | 5,313 | 1,397 | 2,608 | - |
| ROE (net income / shareholders' equity) | 12.8% | 15.9% | 14.8% | 21.4% | 12% | 12.3% | 15.5% | 15% |
| ROA (Net income/ Total Assets) | 6% | 6.58% | 6.07% | 8.22% | - | 5.5% | 6.94% | - |
| Assets 1 | 21,031 | 26,448 | 30,609 | 37,215 | - | 40,463 | 46,783 | - |
| Book Value Per Share 2 | 4.720 | 5.550 | 5.920 | 6.950 | 7.690 | 8.430 | 9.770 | 10.50 |
| Cash Flow per Share 2 | 1.110 | 0.6500 | -0.4900 | 1.560 | 3.090 | 2.770 | 2.180 | -0.0200 |
| Capex 1 | 659 | 1,037 | 1,515 | 1,565 | 1,511 | 1,746 | 1,625 | 1,173 |
| Capex / Sales | 1.77% | 2.17% | 2.74% | 2.28% | 2.49% | 2.62% | 2.24% | 1.46% |
| Announcement Date | 2/6/20 | 2/4/21 | 2/9/22 | 2/7/23 | 2/1/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
14.72
CNY
Average target price
17.25
CNY
Spread / Average Target
+17.19%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.58% | 4.31B | |
| +12.06% | 107B | |
| -0.37% | 29.43B | |
| +12.05% | 22.21B | |
| -14.21% | 17.75B | |
| -6.34% | 17.25B | |
| +10.46% | 15.28B | |
| -4.71% | 12.2B | |
| -1.97% | 10.42B | |
| -8.86% | 9.04B |
- Stock Market
- Equities
- 601231 Stock
- Financials Universal Scientific Industrial (Shanghai) Co., Ltd.
